Abakkus Flexi Cap Fund
The scheme seeks to generate capital appreciation & provide long-term growth opportunities through equity and equity related instruments by investing in a diversified portfolio of large cap, mid cap and small cap securities and the secondary objective is to generate consistent returns by investing in debt and money market securities.
Growthvine rating: 3/5 — ranked #25 of 53 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹10.63 (as of 2026-10-01) |
|---|
| AUM | ₹7,395 Cr |
|---|
| Expense ratio | 1.54% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhishek Krishnaswami Srinivas |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −10.85% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 49.4% |
|---|
| Mid cap | 20.1% |
|---|
| Small cap | 30.5% |
|---|
Concentration
| Top 5 holdings | 19.9% |
|---|
| Top 10 holdings | 33.6% |
|---|
| Total holdings | 46 |
|---|
| Index overlap | 26.0% |
|---|
| Active share | 74.0% |
|---|
Top holdings
- Triparty Repo — 6.5%
- ICICI Bank Ltd. — 5.5%
- HDFC Bank Ltd. — 4.4%
- State Bank Of India — 3.9%
- Reliance Industries Ltd — 3.1%
- Divis Laboratories Ltd. — 3.0%
- NTPC Limited — 2.9%
- Oracle Financial Services Software Limited — 2.8%
- Larsen & Toubro Limited — 2.7%
- INOX India Limited — 2.7%
Top sectors
- Banking & Financial — 22.8%
- Pharma & Biotech — 8.1%
- Automobile — 6.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 6.0% | Q1 (Top) | #3 of 50 |